Haroon Mohammad Selected Research

Mupirocin (Bactroban)

1/2021	Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs.
1/2021	Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice.
1/2020	Auranofin Rapidly Eradicates Methicillin-resistant Staphylococcus aureus (MRSA) in an Infected Pressure Ulcer Mouse Model.
3/2016	Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
1/2015	Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haroon Mohammad Research Topics

Disease

19	Infections 01/2021 - 02/2014
5	Wounds and Injuries (Trauma) 12/2019 - 01/2015
4	Staphylococcal Infections 07/2016 - 01/2015
3	Pressure Ulcer (Bedsore) 01/2021 - 01/2020
3	Suppuration 01/2021 - 01/2020
3	Wound Infection (Wound Infections) 07/2018 - 01/2015
3	Invasive Fungal Infections 01/2018 - 01/2017
3	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2015
1	Ulcer 01/2021
1	Candidiasis (Moniliasis) 12/2019
1	Gram-Positive Bacterial Infections 05/2018
1	Endocarditis 01/2018
1	Sepsis (Septicemia) 01/2018
1	Mycoses (Diseases, Fungus) 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Cryptococcosis 01/2017
1	Rheumatoid Arthritis 01/2017
1	Necrosis 03/2016

Drug/Important Bio-Agent (IBA)

18	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2015
5	Mupirocin (Bactroban)FDA LinkGeneric 01/2021 - 01/2015
5	Auranofin (Ridaura)FDA Link 01/2021 - 03/2016
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2015
4	Antifungal AgentsIBA 12/2019 - 01/2017
4	Fusidic Acid (Fucithalmic)IBA 12/2019 - 03/2016
4	Vancomycin FDA LinkGeneric 11/2019 - 01/2018
3	CytokinesIBA 01/2021 - 11/2015
3	ebselenIBA 01/2021 - 01/2017
2	Linezolid (Zyvox)FDA Link 01/2021 - 06/2018
2	Clindamycin (Cleocin)FDA LinkGeneric 01/2021 - 01/2020
2	Antimicrobial PeptidesIBA 01/2017 - 01/2015
2	Fluconazole (Zonal)FDA LinkGeneric 01/2017 - 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	anthranilic acid (anthranilate)IBA 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	Flufenamic AcidIBA 01/2020
1	Meclofenamic Acid (Meclofenamate)FDA LinkGeneric 01/2020
1	tolfenamic acidIBA 01/2020
1	staphyloxanthinIBA 06/2019
1	Niclosamide FDA Link 06/2018
1	Peptides (Polypeptides)IBA 01/2017
1	Flucytosine (Ancobon)FDA Link 01/2017
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2017
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	Anti-Infective Agents (Microbicides)IBA 03/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2016
1	Leukocidins (Leukocidin)IBA 11/2015
1	Simvastatin (Zocor)FDA LinkGeneric 11/2015
1	Hemolysin Proteins (Hemolysins)IBA 11/2015
1	ThiazolesIBA 01/2015
1	PeptidomimeticsIBA 01/2015
1	Methicillin (Metin)FDA Link 02/2014

Therapy/Procedure

3	Therapeutics 01/2017 - 01/2015